This activation affects transcription factors such as HES and HEY, whose abnormal expression is linked to neuroinflammation and apoptosis in AD, underscoring the pathway’s complex role in the disease’s progression (Boyko et al., 2012; Leal et al., 2012). This evidence concerns the gene RRBP1 and Alzheimer disease.